Specific inhibition of sarcoma-specific cellular immunity by sera from patients with growing sarcomas.
D000912:Antibodies, Neoplasm; D001859:Bone Neoplasms / Q000276:immunology; D002294:Carcinoma, Squamous Cell / Q000276:immunology*; D002460:Cell Line; D002478:Cells, Cultured; D046508:Culture Techniques; D003601:Cytotoxicity Tests, Immunologic; D005347:Fibroblasts; D006801:Humans; D007111:Immunity, Cellular; D007457:Iodine Radioisotopes; D008175:Lung Neoplasms / Q000276:immunology*; D008214:Lymphocytes / Q000187:drug effects*; D012516:Osteosarcoma / Q000276:immunology*; D012008:Recurrence; D012208:Rhabdomyosarcoma / Q000276:immunology*; D012509:Sarcoma / Q000276:immunology
D000912:Antibodies, Neoplasm; D007457:Iodine Radioisotopes